EpCAM-Targeted Antibodies Pipeline Review - Pipelinereview

Skip to main content Skip to footer

Home
News Channels
Reports
Press Room
Contact Us
About Us

Search ...

This product provides basic information on antibody therapy candidates in R&D targeting EpCAM.

PipelineReview.com is powered by La Merie Business IntelligenceFor immediate assistance, please call us during business hours:
Mon-Fri 10:00am - 05:00pm; GMT+01La Merie Publishing - Ulrich Martin
Veinat Puigsec - Can Magí s/n | 17862 Vallfogona de Ripollès | Spain | T +34-87-200 1365 | Email info@lamerie.com

All contents © by La Merie Publishing

Terms and Conditions
Privacy Policy
Submit your Press Release
Imprint

Programa Kit Digital cofinanciado por los fondos Next Generation (EU)
del mecanismo de recuperación y resilencia